Nonchemotherapy drug‐induced cytopenias: A cost‐of‐illness study using the microcosting methodology based on real‐world data
British Journal of Clinical Pharmacology2025
Citations Over Time
Ivana Stević, Slobodan Јаnkovic, Nemanja Petrović, Nataša Čanak‐Baltić, Valentina Marinković, Dragana Lakić
Abstract
Our study showed that the use of healthcare services and costs caused by nonchemotherapy drugs are considerable. Proactive strategies to manage and prevent drug-induced cytopenias should be considered.
Related Papers
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION(2018)
- → Genentech taps Affimed’s antibodies(2018)
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria(1988)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)